Logo
Vishal Chavan @go_67beefe85aabe
Future Outlook: Research and Emerging Therapies for Primary Sclerosing Cholangitis

Why Finding a Cure is Challenging
PSC is rare and has a complex, multifactorial origin. Its unpredictable course, silent progression, and diverse presentation make large clinical trials difficult. However, progress is being made on many fronts.
Current Treatments and Limitations
Currently, no FDA-approved medication halts Primary Sclerosing Cholangitis progression. Symptomatic treatments and liver transplants are the primary options. But research is shifting toward disease-modifying therapies.

Primary Sclerosing Cholangitis Market

https://www.coherentmarket...

#PrimarySclerosingCholangitis , #LiverHealth , #PSCawareness ,
#ChronicLiverDisease , #AutoimmuneLiverDisease , #CoherentMarketInsights .
06:52 AM - Apr 09, 2025 (UTC)

No replys yet!

It seems that this publication does not yet have any comments. In order to respond to this publication from Vishal Chavan, click on at the bottom under it